Cargando…
A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways
BACKGROUND: Metformin and phenformin, biguanide derivatives that are widely used to treat type 2 diabetes mellitus, have recently been shown to exert potential anticancer effects in prostate cancer. This study compared the antiprostate cancer effects of the novel biguanide derivative IM176 with thos...
Autores principales: | Kim, Yunlim, Yoo, Sangjun, Lim, Bumjin, Hong, Jun Hyuk, Kwak, Cheol, You, Dalsan, Hwang, Jung Jin, Kim, Choung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318334/ https://www.ncbi.nlm.nih.gov/pubmed/37409095 http://dx.doi.org/10.1016/j.prnil.2022.11.003 |
Ejemplares similares
-
Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)
por: LEHRER, STEVEN
Publicado: (2020) -
The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021) -
Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?
por: Yoo, Sagnjun, et al.
Publicado: (2021) -
AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
por: Chun, Yoomi, et al.
Publicado: (2021) -
Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle-Invasive Bladder Cancer?
por: Yoo, Sangjun, et al.
Publicado: (2011)